Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Oliver & Co who wrote (2524)	10/28/1997 12:12:00 AM
From: Oliver & Co	Respond to of 6136

This is interesting. I guess the wise follow the wise. -------------------------------------------------------------------------------- Malaysia/Index/Midday -2: Plunges In Regional Mkts Cited -------------------------------------------------------------------------------- October 28, 1997 04:57:15 GMT HTS - HTS -------------------------------------------------------------------------------- KUALA LUMPUR (Dow Jones)--Shares on the Kuala Lumpur Stock Exchange Tuesday continue to nosedive in response to plunges in stock exchanges across the region. At the midday break, the Composite Index, which tracks 100 blue chip stocks, was at 651.30 points, down 42.09 points, or 6.1% "The KLSE is falling because everyone is falling," said an investment analyst at a foreign brokerage house. "And everyone is falling because of everyone else," he added. - - 10-27-97 2357EST

To: Oliver & Co who wrote (2524)	11/2/1997 1:03:00 AM
From: cherry grove	Respond to of 6136

Attended an AIDS treatment conference to discuss ICAAC held in Toraonto. This was held in NYC at St. Vincent's Hosp. auditorium. Viracept was warmly received. I spoke to a PWA who was taking Crixavan and he stated that if Viracept had been available, he would of opted for it (being more user friendly). Crixivan users must follow a strict regimen schedule and that must be incorporated into one's business and social schedule. In addition, an AIDS Doctor Specialist (humanitarian type) from the "East Village" was the guest speaker and lectured. Many of his patients are substance abuse users. He stated that he would never prescribe Crixivan to these people as they would almost always fail that is not being able to adhere to the strict regimen schedule. Also, Roche's Saguiniver has been completely removed from the recommended list by "the guidelines" for anti-retroviral tri-therapy. Mean while Roche is scrambling to get FDA approved of a new soft gel version of Saguinver called Fortovase which is better absorbed. I spoke to clinical trials and 1250 mg. three times a day are reguired and diahrera is a side effect. Incidently, Roche has just begun clinical trial studies at Beth Israel, a study of Fortovase & Nelfinivar as dual protease inhibitors. Also, a new interesting nucluside drug called Combovir (Glaxo) which incorporates AZT & 3TC together in one pill thus eliminating taking two nuclusides with a PI. Please correct me if I'm wrong. Oliver, you being a doctor, I'm interested in your response. Cherry